NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Ancient Clues to Psychoactive Plants in Scripture
From mandrake to manna, a closer look at Scripture’s sacred plants. [...] Read More... The post Ancient Clues to Psychoactive Plants in Scripture appeared first on DoubleBlind Mag.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
In a development that could ripple across the fast evolving neuroplastogen sector, Enveric Biosciences announced that a Post Grant Review petition filed against one of its key U.S. patents has been withdrawn. The deci...
New RAND Report Shows Therapeutic Use Driving U.S. Views Towards Psychedelics
A new report from the RAND Corporation shows that nearly one-quarter of U.S. adults now support the legal use of psilocybin with public support driven by approval for therapeutic not personal access or recreational us...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Scott Shannon, MD What if classic psychedelic medicines like psilocybin don’t heal primarily by changing brain chemistry, but by changing how reality itself is perceived? In clinical psychedelic work and research, we’...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling
Policy Round-Up: State Momentum, Congressional Signals, and Colorado’s Data Build-Out • RAND Survey: Americans Divided on Psilocybin Legalisation • Helus’ Phase 2a Study of Intravenous DMT in MDD Published in Nat...
Psychedelics and Death Anxiety: An Experiential Salve for Existential Distress?
Despite death being universal, Western society and modern medicine tend to deny and fear it, which prevents individuals from confronting mortality in a way that could foster peace, reduce fear, and ultimately enrich h...
Psychedelics Clinical Trial Update: Positive Results from Psilocybin and DMT on the Road for FDA Approval
Clinical updates from Compass Pathways and Helus Pharma from last week marked a significant step forward in the psychedelics development landscape, with new data emerging from late stage and mid stage programs targeti...
What should you listen to while tripping?: 5 Questions with auditory neuroscientist Nikolas Francis
Francis discusses how mice on psilocybin reveal the brain’s responses to sounds.
The Psychedelic News Feed: February 16 – 22, 2026
Your one-stop digest for the latest coverage of psychedelics business, policy, research and beyond, for the week commencing February 16, 2026.
The Rumors Are True: Wooks Are Getting Their Own Dating Show
PLUS iboga for OCD, psychedelics for religious guilt, and the dangers of AI around mushroom science. [...] Read More... The post The Rumors Are True: Wooks Are Getting Their Own Dating Show appeared first on DoubleBli...
Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future
Industry insiders weigh in on the growing pains of Oregon's regulated psilocybin program which has seen concerns raised about licensing fees and some service centers close. The post Oregon’s Psilocybin Program: Indust...
When Therapy Stops Helping
This week’s Sunday Insider: Therapy helped me for years…until it quietly stopped producing change.
A Metamorphosis Through Time
Martha Allitt reflects on the fear of ageing, prompting her to ask others about how psychedelics shape our relationship with growing older. The post A Metamorphosis Through Time appeared first on Chemical Collective.
Seeing What Is There book talk selection
Powerhouse Books, Brooklyn, with Daniel Ehrenhaft, Blackstone Books
Psychedelics and Apeirophobia: Can Altered States Evoke a Fear of Eternity?
Psychedelics are often associated with decreases in death anxiety, but research has shown that many people experience an increase in their fear of death after psychedelic experiences. Could this sometimes due to dread...